コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 A5), HSPA8, HSPD1, and PPIA (peptidyl-propyl cis-trans isomerase).
2 es a presumptive periplasmic peptidyl-prolyl cis-trans isomerase.
3 as a result of a mutation in the carotenoid cis-trans isomerase.
4 the CTD induced by the Ess1 peptidyl-prolyl cis/trans isomerase.
5 tA), the latter coding for a peptidyl-prolyl cis/trans isomerase.
6 hich specifies a periplasmic peptidyl-prolyl cis/trans isomerase.
7 This step is catalyzed by peptidyl-prolyl cis-trans isomerases.
8 me, eIF4E/m(7)GTP, and human peptidyl-prolyl cis-trans isomerase 1 (Pin1) in complex with the peptide
9 on proteins of Tau and Pin1 (peptidyl-prolyl cis-trans-isomerase 1) carrying complementary fragments
10 BISPHOSPHATASE (SBPase), the PEPTIDYL-PROLYL CIS-TRANS ISOMERASE 20-3 (CYP20-3), and ENOLASE2 (ENO2).
11 Cyclophilin A, also known as peptidylprolyl cis-/trans-isomerase A (PPIA), as a foldase is beneficia
12 cyclophilin A, also known as peptidylprolyl cis-/trans-isomerase A (PPIA), is a mediator of the neur
13 two peptides encoded by the peptidyl-prolyl cis-trans isomerase A (PPIA) gene whose abundance was in
14 Cyclophilin A, also known as peptidyl-prolyl cis-trans isomerase A (PPIA), is a foldase and molecular
16 n esterase, a transposase, a peptidyl-prolyl cis-trans isomerase, a subtilisin inhibitor-like protein
18 hilin B in the complex shows peptidyl-prolyl cis-trans isomerase activity and that the P3H1.CRTAP.Cyp
19 e first time a direct role of peptidylprolyl cis-trans isomerase activity has been implicated in the
21 ecretory pathway and suggest that the prolyl cis-trans isomerase activity of FKBP65 may be important
23 pB) is a 21-kDa protein with peptidyl-prolyl cis-trans isomerase activity that functions as a transcr
24 a) cell membranes, has robust peptidylprolyl cis-trans isomerase activity that is strongly inhibited
28 nally normal as judged by its peptidylprolyl cis-trans-isomerase activity and its inhibition by cyclo
30 ally designed to abolish the peptidyl-prolyl cis-trans-isomerase activity of the protein failed to in
31 yclosporin A (CsA)-sensitive, peptidylprolyl cis-trans-isomerase activity that is characteristic of n
32 that CYP38 does not possess peptidyl-prolyl cis/trans isomerase activity and identifies a possible i
33 ophilin A and influences its peptidyl-prolyl cis/trans isomerase activity on residue Pro(314) of NS5A
37 lar cyclophilins function as peptidyl-prolyl cis-trans isomerases and are targets of the immunosuppre
38 d intracellular protein, is a peptidylprolyl cis-trans-isomerase and the major target of the potent i
39 een identified as a secreted peptidyl-prolyl cis/trans isomerase and chaperone that is dispensable fo
40 conserved mechanism of dual functionality in cis/trans isomerases and define its molecular determinan
41 sights into the mechanism of peptidyl-prolyl cis/trans isomerases and the general interplay between e
43 n-disulfide isomerase (PDI), peptidyl-prolyl cis-trans isomerase, and immunoglobulin-binding protein
46 e secreted antigen A and the peptidyl-prolyl cis-trans isomerase, as well as the Enterococcus faecali
47 proteoglycan 1 (LEPRE1) and peptidyl prolyl cis-trans isomerase B (PPIB) genes result in phenotypes
48 ects in the Escherichia coli peptidyl-prolyl cis/trans-isomerase B following mutation of two phenylal
49 two distinct types (racemases/epimerases and cis-trans isomerases), but reactions entailing structura
50 heir access to inward-facing peptidyl-prolyl cis/trans isomerase catalytic sites and ipsilateral chap
51 pite the fact that CypA is a peptidyl-prolyl cis/trans isomerase, catalytic activity on CA(N) has not
53 desaturases (CrtP and CrtQ) and a plant-like cis-trans isomerase (CrtH) and thus differs from the pat
57 1) incorporates the cellular peptidyl-prolyl cis-trans isomerase cyclophilin A (CyPA), the cytosolic
60 tion to the cyclophilin-like peptidyl-prolyl cis-trans isomerase domain, the latter contain a variety
61 an FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain, making them attractive targe
62 ene, tentatively named PPIE (peptidyl-prolyl cis-trans isomerase E), has 83% amino acid identity with
63 ne of at least two predicted peptidyl-prolyl cis/trans-isomerases encoded by L. monocytogenes; these
64 Finally, two immunophilins, peptidyl-prolyl cis-trans isomerase F and FKBP52, the latter of which pl
66 s in FKBP10, which encodes the 65 kDa prolyl cis-trans isomerase, FKBP65, in 38 members of 21 familie
67 lpha-helical linker of the bacterial proline cis/trans isomerase FkpA and the periplasmic oxidase Dsb
69 of the cyclophilin family of peptidyl-prolyl cis-trans isomerases has been isolated from the human pa
71 secreted protein (HP1286); putative peptidyl cis-trans isomerase (HP0175); six proteins encoded by HP
76 t prsA2, an extracytoplasmic peptidyl-prolyl cis/trans isomerase, is critical for virulence and contr
78 mutations in PPIL4, encoding peptidyl-prolyl cis-trans isomerase-like 4, in both familial and index I
80 udies have shown that Pin1, a peptidylprolyl cis/trans-isomerase, may be actively involved in the reg
81 al reaction centre for aldoxime dehydratase, cis-trans isomerase, N-N bond formation, hydrazine forma
83 is coupled with binding of a peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) to p53-RS,
84 ing the protein stability of peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1), a key dri
85 lane/sulfolene inhibitors of peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1), a phospho
86 S-transferase Pi (GSTP1) and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1), emerging
87 s MATalpha1 interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1), which blo
90 rly protein 6 (HPV16 E6) and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 protein (Pin1).
93 ut competitive inhibitors of peptidyl-prolyl cis-trans isomerases or that dipeptides are subject to d
94 ently we have shown that the peptidyl-prolyl cis/trans isomerase parvulin 17 (Par17) interacts with t
101 tability is regulated by the peptidyl-prolyl cis/trans isomerase Pin1 and highlight the importance of
102 ssion levels of an oncogenic peptidyl-prolyl cis/trans isomerase Pin1 and levels of Akt phosphorylati
103 ex containing cyclin E, Cdk2, and the prolyl cis/trans isomerase Pin1 and promotes the activity of Pi
106 yrosine phosphatase 1B and a peptidyl-prolyl cis-trans isomerase (Pin1) isomerase resulted in potent,
107 iously demonstrated that the peptidyl-prolyl cis-trans isomerase, Pin1, binds and targets PML for deg
109 which is a substrate for the peptidylprolyl cis/trans isomerase, Pin1, as well as the ERK1/2 kinases
110 enzymological studies, FKBP38 peptidylprolyl cis/trans isomerase plays an important role in membrane
111 adhesins (VompA and VompB), peptidyl-prolyl cis-trans-isomerase (PpI), and hemin-binding protein E (
113 ose members typically exhibit peptidylprolyl cis-trans isomerase (PPIase) activity which is inhibitab
114 sis of CyPD that compromises peptidyl-prolyl cis-trans isomerase (PPIase) activity, we demonstrate th
119 etween CypB (which possesses peptidyl-prolyl cis-trans isomerase (PPIase) and chaperone functions) an
120 Cyclophilin A is a conserved peptidyl-prolyl cis-trans isomerase (PPIase) best known as the cellular
121 n this study, we demonstrate that the prolyl cis-trans isomerase (PPIase) cyclophilin A (CypA) is hij
122 tratricopeptide domain and a peptidyl-prolyl cis-trans isomerase (PPIase) domain, prevents tau cleara
123 unophilins, a superfamily of peptidyl-prolyl cis-trans isomerase (PPIase) enzymes have been shown to
126 ssembly were inhibited by the peptidylprolyl cis-trans isomerase (PPIase) inhibitors cyclosporin A (C
128 ranslocation chaperone and a peptidyl prolyl cis-trans isomerase (PPIase) that contributes to the vir
129 BP42/Twisted Dwarf1 (TWD1), a peptidylprolyl cis-trans isomerase (PPIase), but all attempts to demons
130 demonstrate that a cellular peptidyl-prolyl cis-trans isomerase (PPIase), cyclophilin B (CyPB), is c
131 ome-associated chaperone and peptidyl-prolyl cis-trans isomerase (PPIase), is essential for the secre
133 r 1 was utilized to confirm peptidyl-prolyl cis-trans-isomerase (PPIase) activity by a PPIase assay
135 ence homology, but both have peptidyl prolyl cis/trans isomerase (PPIase) activity that is involved i
138 be the human protein Pin1, a peptidyl-prolyl cis/trans isomerase (PPIase) that interacts with NIMA.
139 n immunophilin that possesses peptidylprolyl cis/trans-isomerase (PPIase) activity and is a component
140 binding proteins (FKBPs) are peptidyl-prolyl cis/trans isomerases PPIases) that bind the immunosuppre
143 ccordingly, the rER-resident peptidyl prolyl cis/trans isomerases (PPIases) play an important role in
145 ng protein H16_B0227 and the peptidyl-prolyl cis-trans isomerase PpiB, strongly repress gene expressi
147 erate dehydrogenase (PGHDH), peptidyl-prolyl cis-trans isomerase (PPIF), solute carrier 15 (SLC15), s
149 signaling activates Pin1, a peptidyl-prolyl cis-trans isomerase that binds to Bax and prevents its a
150 cyclophilin 33 (Cyp33) is a peptidyl-prolyl cis-trans isomerase that catalyzes cis-trans isomerizati
151 at CyPB is not the exclusive peptidyl-prolyl cis-trans isomerase that catalyzes the rate-limiting ste
152 philin D (PPIF or CypD) is a peptidyl-prolyl cis-trans isomerase that regulates mPTP opening in the i
153 tor is a ribosome-associated peptidyl-prolyl cis/trans isomerase that is highly conserved in most bac
155 coli the ribosome-associated peptidyl-prolyl-cis-trans isomerase, trigger factor, plays a predominant
156 yclophilin A, a well-studied peptidyl-prolyl cis-trans isomerase, using normal and accelerated, atomi
157 and zeta-carotene desaturase [ZDS]), and two cis-trans isomerases (zeta-carotene isomerase [ZISO] and